Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Smeland, Sigbjørn, Bielack, Stefan S., Whelan, Jeremy, Bernstein, Mark, Hogendoorn, Pancras, Krailo, Mark D., Gorlick, Richard, Janeway, Katherine A. +44 more·2019·European Journal of Cancer

Cited by (720)

Items 701–720 of 720

  1. Integrated multi-omic analysis of pediatric metastatic osteosarcoma reveals endothelial cell plasticity and lineage infidelity
    Julian Burks, Ying Wu, Krithika Bhuvaneshwar, Neeraja Syed, Dahee Jung, Carly M. Sayers, Demond Williams, Swapna Vidhur Daulatabad, Therry Malone, Julie Galindo et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Osteosarcoma: A Comprehensive Literature Review on Epidemiology, Pathogenesis, Diagnosis, and Evolving Therapeutic Strategies
    Dominicus Dimitri, Komang Septian Sandiwidayat · 2026 · International Journal of Research and Review
  3. Osteosarcomas
    Philippe Anract, Fréderique Larousserie, Marie Desportes, Camille Tlemsani · 2026 · EMC - Aparato Locomotor
  4. The Role of Alveolar Pneumocytes in the Lung Microenvironment of Osteosarcoma Metastases
    Janice S. Pereira, Lauren E. McGee, Anjali Garg, Kate I. Silver, Troy A. McEachron, Christina N. Mazcko, Amy Kathleen LeBlanc, Jessica A. Beck · 2026 · Research Square
  5. Incidence of Osteosarcoma and the Impact of Treatment on Survival: A Population‐Based Study
    Yinghao Cao, Tongtong Liu, Weisong Zhao, Mengpan Li, Lingfeng Yu, Zhengdong Cai, Tao Zhang · 2026 · International Journal of Clinical Practice
  6. Prognostic factors in pediatric osteosarcoma presenting with pulmonary metastasis: experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
    Elena I. Konopleva, Н. Г. Ускова, Талыпов Сергей Римович, Sergey V Orlov, Олег Иванович Быданов, N. A. Bolshakov, Дмитрий Гурамович Ахаладзе, Galina A. Novichkova, Николай Сергеевич Грачев, Alexander I. Karachunskiy · 2026 · Pediatric Hematology/Oncology and Immunopathology
  7. Assessment of Clinical Time Intervals Along the Patient Journey with Overall Survival in Localized Osteosarcoma and Ewing Sarcoma: A 20-Year Tertiary Sarcoma Centre Experience
    Roberta Laranga, Cristina Ferrari, Federica Zuccheri, Valentina Clementi, Giuseppe Bianchi · 2026 · Cancers
  8. Osteosarcoma Across the Age Spectrum: Why Outcomes Diverge and Trials Must Adapt
    Samantha H. Collins, Igor Matushansky · 2026 · Journal of Clinical Medicine
  9. Maskierte kindliche pathologische Femurfraktur
    Felix Jung, Katrin Luise Voith, Francisco Ferandez · 2026 · Die Unfallchirurgie
  10. Minimal residual disease and relapse surveillance in osteosarcoma: an action-linked framework integrating liquid biopsy and imaging biomarkers
    Guoli Huang, Yang Zhou, Hao Wang, Ma Xiucai · 2026 · Journal of bone oncology
  11. Lymphocyte-to-monocyte ratio predicts survival in localized osteosarcoma in Vietnamese patients
    Tran Thi Thu Hien, Dat Nguyen Quoc, Tran Duc Thanh, Tran Tuyet Thanh Hai, Nguyen Tran Quang Sang, Tran Trung Dung, Xuan‐Hung Nguyen, Son Hai Vu · 2026 · iScience
  12. An immunocompetent, multifluorescent resource for real-time analysis of osteosarcoma progression, metastasis, and response to therapy
    Taiana Campos Leite, JUE HOU, Xuehui Geng, Luigi Mancinelli, Abigail L. Sedlacek, Devanshi A. Nayak, Karen Elizabeth Schoedel, Kurt R. Weiss, Robert Julian Binder, Charles P. Lin et al. · 2026 · Science Advances
  13. Spatially coordinated RTK-ERK signaling dynamics shape osteosarcoma single-cell drug response in the lung microenvironment
    Rawan Makkawi, Carol M. R. Halsey, Vaibhav Murthy, Elise C. Manalo, Hugo Cros, Xin Yi, Jessie May Cartier, Matthew Chang, Mark R. Flory, Kelly Guptell et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Survival Outcomes After ICE-Based High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Metastatic Osteosarcoma
    Ayşegül Dumludağ, Alper Topal, Esmanur Kaplan Tüzün, Gizem Yıldırım, Berkan Karadurmuş, İsmail Ertürk, Nuri Karadurmuş · 2026 · Genel Tıp Dergisi
  15. Biomarker-guided immunotherapy in osteosarcoma: from immune microenvironment profiling to patient stratification and combination strategies
    Qingqing Li · 2026 · Frontiers in Medicine
  16. Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis/relapse in osteosarcoma
    Zhangfu Li, Baicheng Yang, Shiqing Liu, Shengji Yu · 2026 · Translational Oncology
  17. Paediatric bone and soft-tissue sarcomas in Ireland: Epidemiology, management and outcomes
    Timothy McAleese, Ann Marie Delaney, Mohammed Al Salah, Matthew Lee, Gary C O'Toole, Alan P. Molloy · 2026 · The Surgeon
  18. Histopathological Response to Neoadjuvant Chemotherapy Assessed Using the Huvos Grading System and its Correlation with Pretreatment Clinicopathological Variables in Osteosarcoma: A Cohort Study from North East India
    Soumi Bhattacharyya, Lopa Mudra Kakoti, Anupam Sarma, Gaurav Das, Partha Sarathi Roy, Jyotiman Nath, Sukanya Gogoi · 2026 · National Journal of Laboratory Medicine
  19. Iron-copper nanozyme-based hydrogels utilizing apoptosis and ferroptosis to increase cuproptosis for osteosarcoma treatment
    Yiqun Zhang, Yiwei Sun, Yuye Cui, Liang Cheng, Yuanyin Wang, Kelong Fan, Xianwen Wang · 2026 · Chemical Engineering Journal
  20. An Interpretable Integer Risk Score for Osteosarcoma Survival: Development and External Validation in a Multicenter Cohort
    Zhihao Ma, Jiayan Wu, Dajiang Sun, Yifei Zheng, Li Liting, Junxiao Su, Wenhao Hu, Xuesong Zhang · 2026 · Research Square